Medicines for Thyroid eye disease

What it is

Thyroid eye disease (also called Graves' orbitopathy or thyroid-associated ophthalmopathy) is an autoimmune condition affecting the tissues around and behind the eyes. It is most often associated with Graves' disease (an autoimmune cause of an overactive thyroid), though it can occur with normal or underactive thyroid function too, and it results from the immune system causing inflammation and swelling of the muscles and fatty tissue in the eye sockets. This can cause a range of eye symptoms and signs: bulging or protrusion of the eyes (a characteristic feature), a "staring" appearance with the eyelids pulled back, gritty, dry, watery or uncomfortable eyes, redness and swelling of the eyelids and around the eyes, sensitivity to light, and, importantly, in some people, double vision (from the eye muscles being affected) and, rarely, a threat to vision (if severe swelling presses on the optic nerve). It has an "active" phase of inflammation lasting months to a couple of years, followed by a "stable" phase. It is more common and more severe in smokers, so stopping smoking is very important. It can significantly affect appearance, comfort, vision and wellbeing. Because it can, in a minority, threaten vision, and because it needs coordinated care alongside the thyroid condition, thyroid eye disease is assessed and managed by specialists.

How it is treated

Thyroid eye disease is managed by specialists (often eye specialists and endocrinologists working together), with the approach depending on the severity and whether it is in the active (inflammatory) or stable phase. Several key principles apply. Stopping smoking is one of the most important things a person can do, as smoking makes the condition worse and less responsive to treatment. Getting the thyroid function well controlled and stable is also important. For milder disease, supportive measures relieve symptoms — such as lubricating eye drops for dryness and grittiness, measures to protect the eyes, and, sometimes, prisms in glasses for double vision. For more active or severe disease, treatments to reduce the immune-driven inflammation are used — such as steroids and other immune-modulating treatments, and, increasingly, specific targeted medicines for moderate-to-severe active disease; these aim to calm the inflammation and protect the eyes during the active phase. Sight-threatening disease (such as pressure on the optic nerve) is a medical emergency needing urgent treatment. Once the disease is stable, corrective surgery can be considered for any lasting effects — such as surgery to reposition the eyes, correct double vision, or improve the eyelids and appearance. Support for the impact on appearance and wellbeing is important. The reassuring message is that thyroid eye disease is managed with a coordinated approach — controlling the thyroid, stopping smoking, treating inflammation in the active phase, and corrective surgery when stable — to protect the eyes and vision and improve symptoms and appearance.